Islet-1 cells are cardiac progenitors present during the entire lifespan: from the embryonic stage to adulthood. 2010

Rami Genead, and Christian Danielsson, and Agneta B Andersson, and Matthias Corbascio, and Anders Franco-Cereceda, and Christer Sylvén, and Karl-Henrik Grinnemo
Department of Medicine, Division of Cardiology, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.

The aim of this study was to longitudinally characterize the distribution of cells actively expressing the progenitor transcription factor islet-1 (Isl1+) during the embryonic life, the postnatal period, and adulthood. In this study, we have used direct immunohistochemical staining toward the protein Isl1 in a longitudinal rat model. Cells actively expressing Isl1 were traced in embryos from gestational day (GD) 11 until adulthood. In early cardiac development (GD 11), the Isl1+ progenitors were located in a greater abundance in the paracardiac regions, areas suggested to be the second heart field. To a lesser extent, Isl1+ cells were present within the bulbotruncal region and the truncus arteriosus. During the following days until GD 15, the Isl1+ cells were mainly observed at the proximal outflow tract (OFT) and at the inflow area of the right atrium. No Isl1+ cells were detected in the left ventricle. Compared with GD 11, more Isl1+ cells seemed to co-express cardiomyocyte markers and a minority of the Isl1+ cells was undifferentiated. Unexpectedly, only few undifferentiated Isl1+ cells were Ki67+ while a lot of TnT+ cardiomyocytes were proliferating in the ventricles. After birth, immature Isl1+ cells were still present in the OFT where they resided until adulthood. Our data suggest that during embryogenesis, Isl1+ cells migrate from extracardiac regions into the proximal part of the heart, proliferating and giving rise to cardioblasts. Unexpectedly, only a minority of the Isl1+ cells while a majority of ventricular cardiomyocytes were proliferating. The Isl1+ cell pool persists into adulthood, which might open up new strategies to repair damaged myocardium.

UI MeSH Term Description Entries
D009206 Myocardium The muscle tissue of the HEART. It is composed of striated, involuntary muscle cells (MYOCYTES, CARDIAC) connected to form the contractile pump to generate blood flow. Muscle, Cardiac,Muscle, Heart,Cardiac Muscle,Myocardia,Cardiac Muscles,Heart Muscle,Heart Muscles,Muscles, Cardiac,Muscles, Heart
D002454 Cell Differentiation Progressive restriction of the developmental potential and increasing specialization of function that leads to the formation of specialized cells, tissues, and organs. Differentiation, Cell,Cell Differentiations,Differentiations, Cell
D006321 Heart The hollow, muscular organ that maintains the circulation of the blood. Hearts
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013234 Stem Cells Relatively undifferentiated cells that retain the ability to divide and proliferate throughout postnatal life to provide progenitor cells that can differentiate into specialized cells. Colony-Forming Units,Mother Cells,Progenitor Cells,Colony-Forming Unit,Cell, Mother,Cell, Progenitor,Cell, Stem,Cells, Mother,Cells, Progenitor,Cells, Stem,Colony Forming Unit,Colony Forming Units,Mother Cell,Progenitor Cell,Stem Cell
D014157 Transcription Factors Endogenous substances, usually proteins, which are effective in the initiation, stimulation, or termination of the genetic transcription process. Transcription Factor,Factor, Transcription,Factors, Transcription
D015415 Biomarkers Measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, ENVIRONMENTAL EXPOSURE and its effects, disease diagnosis; METABOLIC PROCESSES; SUBSTANCE ABUSE; PREGNANCY; cell line development; EPIDEMIOLOGIC STUDIES; etc. Biochemical Markers,Biological Markers,Biomarker,Clinical Markers,Immunologic Markers,Laboratory Markers,Markers, Biochemical,Markers, Biological,Markers, Clinical,Markers, Immunologic,Markers, Laboratory,Markers, Serum,Markers, Surrogate,Markers, Viral,Serum Markers,Surrogate Markers,Viral Markers,Biochemical Marker,Biologic Marker,Biologic Markers,Clinical Marker,Immune Marker,Immune Markers,Immunologic Marker,Laboratory Marker,Marker, Biochemical,Marker, Biological,Marker, Clinical,Marker, Immunologic,Marker, Laboratory,Marker, Serum,Marker, Surrogate,Serum Marker,Surrogate End Point,Surrogate End Points,Surrogate Endpoint,Surrogate Endpoints,Surrogate Marker,Viral Marker,Biological Marker,End Point, Surrogate,End Points, Surrogate,Endpoint, Surrogate,Endpoints, Surrogate,Marker, Biologic,Marker, Immune,Marker, Viral,Markers, Biologic,Markers, Immune
D049109 Cell Proliferation All of the processes involved in increasing CELL NUMBER including CELL DIVISION. Cell Growth in Number,Cellular Proliferation,Cell Multiplication,Cell Number Growth,Growth, Cell Number,Multiplication, Cell,Number Growth, Cell,Proliferation, Cell,Proliferation, Cellular
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus
D060850 LIM-Homeodomain Proteins A subclass of LIM domain proteins that include an additional centrally-located homeodomain region that binds AT-rich sites on DNA. Many LIM-homeodomain proteins play a role as transcriptional regulators that direct cell fate. LIM-Homeodomain Protein,LIM Homeodomain Protein,LIM Homeodomain Proteins,Protein, LIM-Homeodomain

Related Publications

Rami Genead, and Christian Danielsson, and Agneta B Andersson, and Matthias Corbascio, and Anders Franco-Cereceda, and Christer Sylvén, and Karl-Henrik Grinnemo
February 2017, Stem cell reports,
Rami Genead, and Christian Danielsson, and Agneta B Andersson, and Matthias Corbascio, and Anders Franco-Cereceda, and Christer Sylvén, and Karl-Henrik Grinnemo
May 2002, Development (Cambridge, England),
Rami Genead, and Christian Danielsson, and Agneta B Andersson, and Matthias Corbascio, and Anders Franco-Cereceda, and Christer Sylvén, and Karl-Henrik Grinnemo
March 2024, Research square,
Rami Genead, and Christian Danielsson, and Agneta B Andersson, and Matthias Corbascio, and Anders Franco-Cereceda, and Christer Sylvén, and Karl-Henrik Grinnemo
June 1985, The Journal of experimental medicine,
Rami Genead, and Christian Danielsson, and Agneta B Andersson, and Matthias Corbascio, and Anders Franco-Cereceda, and Christer Sylvén, and Karl-Henrik Grinnemo
July 2005, Developmental biology,
Rami Genead, and Christian Danielsson, and Agneta B Andersson, and Matthias Corbascio, and Anders Franco-Cereceda, and Christer Sylvén, and Karl-Henrik Grinnemo
December 2001, Nature biotechnology,
Rami Genead, and Christian Danielsson, and Agneta B Andersson, and Matthias Corbascio, and Anders Franco-Cereceda, and Christer Sylvén, and Karl-Henrik Grinnemo
June 2012, Developmental biology,
Rami Genead, and Christian Danielsson, and Agneta B Andersson, and Matthias Corbascio, and Anders Franco-Cereceda, and Christer Sylvén, and Karl-Henrik Grinnemo
January 2012, Circulation journal : official journal of the Japanese Circulation Society,
Rami Genead, and Christian Danielsson, and Agneta B Andersson, and Matthias Corbascio, and Anders Franco-Cereceda, and Christer Sylvén, and Karl-Henrik Grinnemo
December 2011, European journal of histochemistry : EJH,
Rami Genead, and Christian Danielsson, and Agneta B Andersson, and Matthias Corbascio, and Anders Franco-Cereceda, and Christer Sylvén, and Karl-Henrik Grinnemo
August 2007, Cell cycle (Georgetown, Tex.),
Copied contents to your clipboard!